SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,911.01 31.61
( 0.04%)

Global Indices

Nasdaq

52,502.29 249.40
(0.48%)

Dow Jones

7,647.48 105.55
(1.40%)

Hang Seng

60,763.20 -485.39
(-0.79%)

Nikkei 225

10,823.18 71.59
(0.67%)

Forex

USD-INR

93.57 -0.21
(-0.22%)

EUR-INR

104.78 -0.12
(-0.12%)

GBP-INR

125.37 -0.34
(-0.27%)

JPY-INR

0.59 0.00
(-0.40%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

TCI Finance Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

501242

INE911B01018

-61.4460761

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

TCIFINANCE

18.13

EPS(TTM)

Face Value()

Div & Yield %

Back

Glaxosmithkline Pharmaceuticals consolidated net profit rises 30.44% in the September 2026 quarter

Nov 04,2026

Net profit of Glaxosmithkline Pharmaceuticals rose 30.44% to Rs 335.88 crore in the quarter ended September 2026 as against Rs 257.49 crore during the previous quarter ended September 2025. Sales rose 20.78% to Rs 1183.57 crore in the quarter ended September 2026 as against Rs 979.94 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	1183.57	979.94	21
OPM %	33.97	34.26	-
PBDT	474.36	368.79	29
PBT	459.34	351.36	31
NP	335.88	257.49	30

81,911.01 31.61 ( 0.04%)

52,502.29 249.40 (0.48%)

7,647.48 105.55 (1.40%)

60,763.20 -485.39 (-0.79%)

10,823.18 71.59 (0.67%)

93.57 -0.21 (-0.22%)

104.78 -0.12 (-0.12%)

125.37 -0.34 (-0.27%)

0.59 0.00 (-0.40%)